A Big Pharma client was interested in running analysis to understand competitor real-world evidence (RWE) activities psoriatic arthritis (PsA), in order to assess how competitors are generating & using RWE data to support the success of their late-stage & marketed assets
GlobalData leveraged is established RWE Tracker methodology to monitor RWE generation (RWE study designs, conference abstracts, journal publications) & commercial utilization (company sponsored presentations & exhibit booth content at conferences, press releases, websites) over the past 5 years, across a range of key metrics that are captured in database & report format:
GlobalData provided the client with RWE database updates & presentations throughout the 12-month project following key rheumatology congresses (EULAR & ACR), in addition to providing a full report update in both Excel database, PowerPoint report, & webinar formats.
Client feedback
“As with the Lupus information [real-world evidence CI tracking project], I found the PsA [psoriatic arthritis] info very informative and it even immediately helped to inform the design of a study I had been planning. So, thank-you again for pulling this together.”